Abramson Cancer Center at Pennsylvania Hospital — Philadelphia, Pennsylvania

Abramson Cancer Center at Pennsylvania Hospital is a clinical research site located in Philadelphia, Pennsylvania, United States 19106.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Abramson Cancer Center at Pennsylvania Hospital has participated in 12 clinical trials with 3 currently active.

Therapeutic areas: Locally Advanced or Metastatic Solid Tumors, Liposarcoma, Dedifferentiated, Desmoid Tumor.

Sponsors: Chugai Pharmaceutical, Boehringer Ingelheim, SpringWorks Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center at Pennsylvania Hospital?

Abramson Cancer Center at Pennsylvania Hospital has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center at Pennsylvania Hospital conducted?

Abramson Cancer Center at Pennsylvania Hospital has 12 clinical trials on record, with 3 currently active. Their work covers Locally Advanced or Metastatic Solid Tumors, Liposarcoma, Dedifferentiated, Desmoid Tumor.

Is Abramson Cancer Center at Pennsylvania Hospital accredited by Crixeo Health?

Yes — Abramson Cancer Center at Pennsylvania Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Abramson Cancer Center at Pennsylvania Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.